Background
Methods
Results
Characteristic | Total | Non-Adherent | Adherent | p-value | |||
---|---|---|---|---|---|---|---|
n = 212 | % | n = 91 | (%) | N = 121 | (%) | ||
Place of residence
| |||||||
Urban |
114
|
(53.8)
| 29 |
(31.9)
| 85 |
(70.2)
| <0.001 |
Commercial Farming areas |
41
|
(19.3)
| 27 |
(29.7)
| 14 |
(11.60
| <0.001 |
Peri-urban |
27
|
(12.7)
| 15 |
(16.5)
| 12 |
(9.9)
| 0.15 |
Communal (rural) |
23
|
(10.8)
| 14 |
(15.4)
| 9 |
(7.4)
| 0.06 |
Mining community |
7
|
(3.3)
| 6 |
(6.6)
| 1 |
(0.8)
| 0.05 |
Marital status
| |||||||
Married/co-habiting |
170
|
(80.2)
| 70 |
(76.9)
| 100 |
(82.6)
| 0.30 |
Single |
16
|
(7.5)
| 9 |
(7.4)
| 7 |
(7.7)
| 0.26 |
Divorced/separated |
15
|
(7.1)
| 10 |
(11.0)
| 5 |
(4.1)
| 0.09 |
Widowed |
11
|
(5.2)
| 4 |
(4.4)
| 7 |
(5.8)
| 0.76 |
Highest level of education attained
| |||||||
Up-to primary |
62
|
(29.2)
| 42 |
(46.2)
| 20 |
(16.6)
| <0.001 |
Secondary (up-to form 4) |
138
|
(65.1)
| 46 |
(50.6)
| 92 |
(76.0)
| <0.001 |
Secondary (Form 5 and 6) |
10
|
(4.7)
| 3 |
(3.3)
| 7 |
(5.8)
| 0.40 |
Tertiary |
2
|
(0.9)
| 0 |
(0)
| 2 |
(1.7)
| 0.22 |
Employment status
| |||||||
Formally employed |
26
|
(12.3)
| 4 |
(4.4)
| 22 |
(18.2)
| 0.002 |
Informally employed |
37
|
(17.5)
| 18 |
(19.8)
| 19 |
(15.7)
| 0.44 |
Not employed |
149
|
(70.3)
| 69 |
(75.8)
| 80 |
(66.1)
| 0.13 |
Maternal adherence to nevirapine
Adherence Characteristics | Frequency | 95%CI | |
---|---|---|---|
n = 212 | % | ||
Maternal nevirapine dose
| |||
Swallowed nevirapine at least 2 hrs before delivery | 147 |
69.3
|
62.9-75.3
|
Swallowed nevirapine less than 2 hrs before delivery | 29 |
13.7
|
9.5-18.8
|
Did not swallow nevirapine before delivery | 36 |
17.0
|
12.4-22.5
|
Total maternal non-adherence to NVP | 65 |
30.7
|
24.7-37.1
|
Newborn nevirapine dose
| |||
Swallowed nevirapine within 72 hrs of birth | 155 |
73.1
|
66.8-78.8
|
Swallowed the nevirapine more than 72 hrs after birth | 15 |
7.1
|
4.2-11.2
|
Did not swallow nevirapine after birth | 42 |
19.8
|
14.9-25.6
|
Total newborn baby non-adherence to nevirapine | 57 |
26.9
|
21.2-33.2
|
Combined maternal-infant nevirapine doses
| |||
Mother, baby or both took NVP within recommended time | 121 |
57.1
|
50.3-63.6
|
Mother, baby or both took NVP outside recommended time | 25 |
11.8
|
8.0-16.7
|
Mother, baby or both did not swallow nevirapine | 66 |
31.1
|
25.2-37.6
|
Combined mother-baby non-adherence to NVP | 91 |
42.9
|
36.4-49.7
|
Infant adherence to nevirapine
Mother-baby pair adherence to nevirapine
Nevirapine accessibility and maternal adherence
Place of delivery and nevirapine adherence
Self-disclosure of HIV results and nevirapine adherence
Ability to afford paying for ANC services and nevirapine adherence
Factors associated with nevirapine non-adherence: bivariate analyses
Variable | SD-NVP Adherence status | POR | 95% CI | |||
---|---|---|---|---|---|---|
Non-Adherent | Adherent | |||||
n = 91 | (%) | n = 121 | (%) | |||
Resides in a farming or rural settlement | 41 | (45.1) | 23 | (19.0) |
3.49
|
1.89-6.45
|
Unable to afford paying for health services | 39 | (42.9) | 24 | (19.8) |
3.40
|
1.82-6.33
|
No maternal secondary education | 42 | (46.2) | 20 | (16.5) |
4.33
|
2.30-8.15
|
Stays with in-laws in same household | 20 | (22.0) | 14 | (11.6) |
2.15
|
1.02-4.54
|
Belongs to a restrictive religion | 31 | (34.1) | 23 | (19.0) |
2.20
|
1.17-4.12
|
Used herbal medicine during pregnancy | 29 | (31.9) | 12 | (9.9) |
4.25
|
2.02-8.92
|
Did not disclose HIV status to partner | 57 | (62.6) | 53 | (43.8) |
2.15
|
1.23-3.75
|
Attended less than three ANC sessions | 14 | (15.4) | 5 | (4.1) |
4.22
|
1.46-12.19
|
Delivered at home | 48 | (52.7) | 6 | (5.0) |
21.40
|
8.54-53.59
|
Exposed to PMTCT in previous pregnancy | 17 | (18.7) | 56 | (46.3) |
0.27
|
0.14-0.50
|
Received a nevirapine tablet during ANC | 61 | (67.0) | 117 | (96.7) |
0.07
|
0.02-0.20
|
Mother not gainfully employed | 68 | (74.7) | 80 | (66.1) | 1.16 | 0.84-3.10 |
Multi-parity (4th child and above) | 25 | (27.5) | 21 | (17.4) | 1.80 | 0.93-3.48 |
Factors associated with nevirapine non-adherence: logistic regression analyses
Risk Factor | POR | 95% CI |
---|---|---|
Combined mother-baby pair non-adherence to nevirapine
| ||
No maternal secondary education |
2.58
|
1.11-6.00
|
Delivered at home (out of the health system) |
24.87
|
8.37-73.93
|
Exposed to PMTCT in previous pregnancy (s) |
0.17
|
0.07-0.44
|
Mother given a nevirapine tablet to take home during ANC |
0.06
|
0.02-0.21
|
Non-adherence to the maternal dose of nevirapine
| ||
No maternal secondary education |
2.38
|
1.05-3.39
|
Multi-parity (4th baby and above) |
2.66
|
1.05-6.72
|
Mother given a nevirapine tablet to take home during ANC |
0.03
|
0.01-0.09
|
Exposed to PMTCT in previous pregnancy (s) |
0.22
|
0.08-0.57
|
Non-adherence to the infant dose of nevirapine
| ||
Born at home (out of the health system) |
48.76
|
17.51-135.82
|
Mother did not disclose HIV results to partner |
2.75
|
1.04-7.32
|